Pharma Equity Group A/S

Pharma Equity Group A/S Enterprise Value

The Enterprise Value (EV) of Pharma Equity Group A/S (PEG.CO) as of Oct 17, 2026 is 123.19 M DKK. In the previous year, Enterprise Value (EV) was 125.14 M DKK — a change of -1.55% (lower).

Enterprise Value

123.19 MDKK

YoY

-1.55%

Last updated:

Enterprise Value (EV) of Pharma Equity Group A/S is 2025 123.19 M DKK. Enterprise Value (EV) of Pharma Equity Group A/S was 2024 125.14 M DKK. It decreases by -1.55% lower compared to the previous year.

The Pharma Equity Group A/S Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
117.12 M DKK
Jan 1, 2019
117.30 M DKK
Jan 1, 2020
125.68 M DKK
Jan 1, 2021
134.56 M DKK
Jan 1, 2022
138.29 M DKK
Jan 1, 2023
141.63 M DKK
Jan 1, 2024
125.14 M DKK
Jan 1, 2025
123.19 M DKK
The Pharma Equity Group A/S Enterprise Value history
YEAREnterprise ValueYoY
123.19 MDKK-1.55%
125.14 MDKK-11.64%
141.63 MDKK+2.41%
138.29 MDKK+2.77%
134.56 MDKK+7.07%
125.68 MDKK+7.14%
117.30 MDKK+0.15%
117.12 MDKK+1.20%
115.74 MDKK-4.69%
121.43 MDKK-11.22%
136.78 MDKK+18.27%
115.65 MDKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

Enterprise Value (EV) of Pharma Equity Group A/S is 123.19 M DKK in 2025.

Enterprise Value (EV) of Pharma Equity Group A/S changed from 125.14 M DKK to 123.19 M DKK, representing a -1.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s DKK, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' DKK varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Pharma Equity Group A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pharma Equity Group A/S

All Key Metrics — Pharma Equity Group A/S